Related Experiment Video
Updated: May 2, 2026
14:48
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
4.7K
Lytic Cell Death in Chronic Lung Diseases.
Ioannis Siokas1, Morgan Heileman1, Lawrence C Fritz2
1Program in Genetics, Molecular and Cell Biology, Tufts University School of Medicine, Boston, MA, United States.
Summary
Regulated cell death, specifically pyroptosis and necroptosis, contributes to lung injury in diseases like COPD and IPF. New strategies targeting these cell death pathways are needed to prevent lung tissue damage.
Area of Science:
- Cell Biology
- Immunology
- Pathology
Background:
- Regulated cell death is crucial for tissue homeostasis and immunity.
- Apoptosis is a common, non-inflammatory cell death pathway.
- Necrotic cell death releases inflammatory mediators, often linked to disease.
Purpose of the Study:
- To review the role of pyroptosis and necroptosis in lung diseases.
- To highlight the need for new therapeutic strategies targeting cell death.
- To evaluate the specific cell types and death pathways involved in lung injury.
Main Methods:
- Literature review of current research on regulated cell death in lung diseases.
- Analysis of evidence implicating pyroptosis and necroptosis in disease pathology.
- Identification of cell types affected by these death pathways.
Main Results:
- Pyroptosis and necroptosis are implicated in lung injury and inflammation.
- These cell death pathways contribute to Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF).
- Death of airway/alveolar epithelial and immune cells leads to barrier disruption and inflammation.
Conclusions:
- Regulated necrosis, particularly pyroptosis and necroptosis, drives lung damage in COPD and IPF.
- Targeting these detrimental cell death mechanisms is essential for preventing lung tissue damage.
- Further research is needed to understand the specific roles of cell death pathways and cell types in respiratory disorders.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K